Home > Pharmaceuticals and Healthcare > EMEA (Europe, Middle East and Africa) Non-steroidal Anti-inflammatory Drugs?NSAID? Market Report 2017...

EMEA (Europe, Middle East and Africa) Non-steroidal Anti-inflammatory Drugs?NSAID? Market Report 2017

No. of Pages: 119Published : 05 May 2017

Request Sample
 

In this report, the EMEA Non-steroidal Anti-inflammatory Drugs?NSAID market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Non-steroidal Anti-inflammatory Drugs?NSAID for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Non-steroidal Anti-inflammatory Drugs?NSAID market competition by top manufacturers/players, with Non-steroidal Anti-inflammatory Drugs?NSAID sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including Bayer Novacap Abbott Pfizer Geri-Care Pharmaceuticals Perrigo Company Kopran Merck Sharp & Dohme Sun Pharmaceutical Industries Glaxo Smith Kline Reddy Pharmaceuticals Johnson & Johnson On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into Aspirin Ibuprofen Naproxen Nabumetone Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Non-steroidal Anti-inflammatory Drugs?NSAID for each application, including Back Pain Treatment Osteoarthritis Treatment Other If you have any special requirements, please let us know and we will offer you the report as you want.

 

Table of Contents EMEA (Europe, Middle East and Africa) Non-steroidal Anti-inflammatory Drugs?NSAID? Market Report 2017 1 Non-steroidal Anti-inflammatory Drugs?NSAID? Overview 1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs?NSAID? 1.2 Classification of Non-steroidal Anti-inflammatory Drugs?NSAID? 1.2.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Aspirin 1.2.4 Ibuprofen 1.2.5 Naproxen 1.2.6 Nabumetone 1.2.7 Others 1.3 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market by Application/End Users 1.3.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (Volume) and Market Share Comparison by Application (2012-2022 1.3.2 Back Pain Treatment 1.3.3 Osteoarthritis Treatment 1.3.4 Other 1.4 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market by Region 1.4.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size (Value) Comparison by Region (2012-2022) 1.4.2 Europe Status and Prospect (2012-2022) 1.4.3 Middle East Status and Prospect (2012-2022) 1.4.4 Africa Status and Prospect (2012-2022) 1.5 EMEA Market Size (Value and Volume) of Non-steroidal Anti-inflammatory Drugs?NSAID? (2012-2022) 1.5.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2022) 1.5.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2012-2022) 2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Competition by Players/Manufacturers 2.1.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Market Share of Major Players (2012-2017) 2.1.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Share by Players (2012-2017) 2.1.3 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sale Price by Players (2012-2017) 2.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? (Volume and Value) by Type/Product Category 2.2.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type (2012-2017) 2.2.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Market Share by Type (2012-2017) 2.2.3 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sale Price by Type (2012-2017) 2.3 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? (Volume) by Application 2.4 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? (Volume and Value) by Region 2.4.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Region (2012-2017) 2.4.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Market Share by Region (2012-2017) 2.4.3 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Price by Region (2012-2017) 3 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Value (2012-2017) 3.1.1 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Growth Rate (2012-2017) 3.1.2 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2012-2017) 3.2 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type 3.3 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Application 3.4 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume by Countries (2012-2017) 3.4.2 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2012-2017) 3.4.3 Germany Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 3.4.4 France Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 3.4.5 UK Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 3.4.6 Russia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 3.4.7 Italy Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 3.4.8 Benelux Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 4 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Value (2012-2017) 4.1.1 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Growth Rate (2012-2017) 4.1.2 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2012-2017) 4.2 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type 4.3 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Application 4.4 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume by Countries (2012-2017) 4.4.2 Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2012-2017) 4.4.3 Saudi Arabia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 4.4.4 Israel Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 4.4.5 UAE Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 4.4.6 Iran Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 5 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Value (2012-2017) 5.1.1 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Growth Rate (2012-2017) 5.1.2 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2012-2017) 5.2 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Type 5.3 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Market Share by Application 5.4 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume by Countries (2012-2017) 5.4.2 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue by Countries (2012-2017) 5.4.3 South Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 5.4.4 Nigeria Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 5.4.5 Egypt Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 5.4.6 Algeria Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate (2012-2017) 6 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturers/Players Profiles and Sales Data 6.1 Bayer 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Novacap 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Abbott 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Pfizer 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Geri-Care Pharmaceuticals 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Perrigo Company 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Kopran 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Merck Sharp & Dohme 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Sun Pharmaceutical Industries 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 Glaxo Smith Kline 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Non-steroidal Anti-inflammatory Drugs?NSAID? Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 6.11 Reddy Pharmaceuticals 6.12 Johnson & Johnson 7 Non-steroidal Anti-inflammatory Drugs?NSAID? Manufacturing Cost Analysis 7.1 Non-steroidal Anti-inflammatory Drugs?NSAID? Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs?NSAID? 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Non-steroidal Anti-inflammatory Drugs?NSAID? Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs?NSAID? Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Forecast (2017-2022) 11.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Price Forecast (2017-2022) 11.1.1 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales and Growth Rate Forecast (2017-2022) 11.1.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate Forecast (2017-2022) 11.1.3 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Price and Trend Forecast (2017-2022) 11.2 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.3 Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.4 Middle Eastt Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.5 Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.6 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Forecast by Type (2017-2022) 11.7 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Forecast by Application (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Non-steroidal Anti-inflammatory Drugs?NSAID? Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume (K MT) by Type (2012-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume Market Share by Type (Product Category) in 2016 Figure Aspirin Product Picture Figure Ibuprofen Product Picture Figure Naproxen Product Picture Figure Nabumetone Product Picture Figure Others Product Picture Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume (K MT) by Application (2012-2022) Figure EMEA Sales Market Share of Non-steroidal Anti-inflammatory Drugs?NSAID? by Application in 2016 Figure Back Pain Treatment Examples Figure Osteoarthritis Treatment Examples Figure Other Examples Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Size (Million USD) by Region (2012-2022) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Growth Rate (2012-2022) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) Status and Forecast by Countries Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Growth Rate (2012-2022) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) Status and Forecast by Countries Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Growth Rate (2012-2022) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) Status and Forecast by Countries Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume and Growth Rate (2012-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Growth Rate (2012-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Major Players Product Sales Volume (K MT) (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume (K MT) of Major Players (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Players (2012-2017) Figure 2016 Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Players Figure 2017 Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Players Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Market Major Players Product Revenue (Million USD) (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) by Players (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Share by Players (2012-2017) Table 2016 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Share by Players Table 2017 EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Share by Players Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sale Price (USD/MT) by Players (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Market Share by Type (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Type (2012-2017) Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs?NSAID? by Type (2012-2017) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Type (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Market Share by Type (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Share by Type (2012-2017) Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs?NSAID? by Type in 2016 Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sale Price (USD/MT) by Type (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Market Share by Application (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Application (2012-2017) Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs?NSAID? by Application (2012-2017) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application in 2016 Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Market Share by Region (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Share by Region (2012-2017) Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs?NSAID? by Region (2012-2017) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in 2016 Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Market Share by Region (2012-2017) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Share by Region (2012-2017) Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs?NSAID? by Region (2012-2017) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share Regions in 2016 Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Price (USD/MT) by Region (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate (2012-2017) Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) by Type (2012-2017) Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share by Type (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share by Type in 2016 Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) by Application (2012-2017) Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share by Application (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share by Application in 2016 Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) by Countries (2012-2017) Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries in 2016 Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) by Countries (2012-2017) Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2012-2017) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries in 2016 Figure Germany Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure France Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure UK Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Russia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Italy Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Benelux Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Growth Rate (2012-2017) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) by Type (2012-2017) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share by Type (2012-2017) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share by Type (2012-2017) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) by Applications (2012-2017) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Market Share by Applications (2012-2017) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application in 2016 Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume (K MT) by Countries (2012-2017) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume Market Share by Countries (2012-2017) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume Market Share by Countries in 2016 Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) by Countries (2012-2017) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2012-2017) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2012-2017) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries in 2016 Figure Saudi Arabia Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Israel Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure UAE Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Iran Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) and Growth Rate (2012-2017) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) by Type (2012-2017) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Type (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Type (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Type in 2016 Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) by Application (2012-2017) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Application (2012-2017) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Volume (K MT) by Countries (2012-2017) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share by Countries in 2016 Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) by Countries (2012-2017) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries (2012-2017) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share by Countries in 2016 Figure South Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Nigeria Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Egypt Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Algeria Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Table Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Bayer Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Novacap Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Abbott Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Pfizer Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Kopran Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate (2012-2017) Figure Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share in EMEA (2012-2017) Figure Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share in EMEA (2012-2017) Table Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Johnson & Johnson Non-steroidal Anti-inflammatory Drugs?NSAID? Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs?NSAID? Figure Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs?NSAID? Figure Non-steroidal Anti-inflammatory Drugs?NSAID? Industrial Chain Analysis Table Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs?NSAID? Major Manufacturers in 2016 Table Major Buyers of Non-steroidal Anti-inflammatory Drugs?NSAID? Table Distributors/Traders List Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) and Growth Rate Forecast (2017-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue and Growth Rate Forecast (2017-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Price (USD/MT) and Trend Forecast (2017-2022) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) Forecast by Region (2017-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share Forecast by Region (2017-2022) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) Forecast by Region (2017-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share Forecast by Region (2017-2022) Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) Forecast by Countries (2017-2022) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share Forecast by Countries (2017-2022) Table Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) Forecast by Countries (2017-2022) Figure Europe Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share Forecast by Countries (2017-2022) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) Forecast by Countries (2017-2022) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share Forecast by Countries (2017-2022) Table Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) Forecast by Countries (2017-2022) Figure Middle East Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share Forecast by Countries (2017-2022) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) Forecast by Countries (2017-2022) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share Forecast by Countries (2017-2022) Table Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue (Million USD) Forecast by Countries (2017-2022) Figure Africa Non-steroidal Anti-inflammatory Drugs?NSAID? Revenue Market Share Forecast by Countries (2017-2022) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) Forecast by Type (2017-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share Forecast by Type (2017-2022) Table EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales (K MT) Forecast by Application (2017-2022) Figure EMEA Non-steroidal Anti-inflammatory Drugs?NSAID? Sales Market Share Forecast by Application (2017-2022) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Report ID : MSF45034

Publisher Name : Qy Research

Why Market Size Forecasters?

  • Reports at Lowest Prices - Guaranteed
  • Fastest Growing Research Reports’ Database
  • Easy Customization Options
  • 24 X 7 Support Commitment
  • Certified, Safe & Secured Payments

Have A Question?

Ask UsView FAQ's